<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q318 OrthoBio Market Recap: Acquisitions and Partnerships Rule

Posted by Kim French on 12/14/18 2:28 PM

Acquisitions and Partnerships are Highpoints in Q318

SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...

Among the many topics covered in the Q318 OrthoBio Market Recap are:

Read More

Topics: OrthoBio, Q318 Market Recaps

Q318 Advanced Wound Care Market Recap: All Segments Showing Softness

Posted by Susan Paquette on 12/13/18 1:54 PM

All segments showing softness, lowest quarterly growth rate since 2015

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +3.0% YoY, with Acelity, also known as KCI, maintaining its leadership position with estimated Q318 revenues of...

Read More

Topics: Advanced Wound Care, Q318 Market Recaps

Q318 Joint Fluid Market Recap-Trending Downward Owing to Pricing Declines

Posted by Sharon O'Reilly on 12/5/18 9:55 AM

Pricing pressure continues to dampen the US Joint Fluid market, which experienced a double-digit decline of -9.9% according to SmartTRAK's Financial Dashboard results. While the market continues to expand in terms of the number of patients treated, ASPs have steadily eroded over the past three quarters since the Anthem non-coverage decision kicked in earlier this year. Year-to-date, the US Joint Fluid market slowed significantly, posting negative growth according to SmartTRAK estimates...

Read More

Topics: OrthoBio, OrthoBio-Joint Fluid, Q318 Market Recaps

Q318 Total Joints Market Recap: Easier Comps Drive Improved US Growth

Posted by Lisa Mahan on 12/4/18 9:00 AM

It’s no surprise that Q318 US revenue growth accelerated YoY when, for the same period last year, the US Total Joints Market experienced major market disruption from two major hurricanes which delayed procedures beyond the usual Q3 procedural slowdown. Industry analysts, including Cantor Fitzgerald’s Craig Bijou, report that US recon growth was relatively flat on a stacked two-year basis. From this perspective, SmartTRAK believes this trend confirms the market is not showing major signs of improvement or decline...

Among the many topics covered in detail in the Q318 Total Joints Market Recap are:

Read More

Topics: Orthopedics-Total Joints, Q318 Market Recaps

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts